Search Results - "Kumihashi, Yuki"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Study on prediction of early adverse events by CapeOX therapy in patients with colorectal cancer

    Study on prediction of early adverse events by CapeOX therapy in patients with colorectal cancer by Kumihashi, Yuki, Kasai, Yohei, Akagawa, Takuya, Yuasa, Yasuhiro, Ishikura, Hisashi, Sato, Youichi

    “…CapeOX is a regimen used as postoperative adjuvant chemotherapy for the treatment of advanced recurrent colorectal cancer. If early adverse events occur,…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study

    Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study by Hirata, Taiki, Kawaguchi, Takashi, Azuma, Kanako, Torii, Ayako, Usui, Hiroaki, Kim, Soan, Hayama, Tatsuya, Hirate, Daisuke, Kawahara, Yosuke, Kumihashi, Yuki, Chisaka, Tomomi, Wako, Tetsuya, Yoshimura, Akinobu, Miyaji, Tempei, Yamaguchi, Takuhiro

    Published in BMJ open (22-11-2023)
    “…IntroductionThe use of immune checkpoint inhibitors (ICIs) is rapidly expanding in cancer treatment. ICIs have a unique safety profile, characterised by…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Role of Cancer Chemotherapy Is Expected to Improve PS and QOL

    Role of Cancer Chemotherapy Is Expected to Improve PS and QOL by Ishikura, Hisashi, Kumihashi, Yuki, Fukushima, Yukari, Hagi, Ayumi

    Published in Gan to kagaku ryoho (01-05-2019)
    “…We report three cases of advanced lung cancer with poor PS treated with molecular-targeted drugs and consider the role of cancer chemotherapy to improve…”
    Get more information
    Journal Article
    Save to List
    Saved in:
  4. 4
    Clinical experience of the use of pemetrexed (PEM) combined with cisplatin (CDDP)/Carboplatin (CBDCA) followed by long-term maintenance PEM in patients with non-squamous non-small cell lung cancer

    Clinical experience of the use of pemetrexed (PEM) combined with cisplatin (CDDP)/Carboplatin (CBDCA) followed by long-term maintenance PEM in patients with non-squamous non-small cell lung cancer by Ishikura, Hisashi, Kumihashi, Yuki, Kimura, Suguru, Matsuoka, Yutaka, Matsumoto, Daisuke

    Published in Gan to kagaku ryoho (01-05-2014)
    “…This study evaluated the efficacy and safety of pemetrexed and carboplatin (CBDCA) or cisplatin (CDDP) followed by maintenance pemetrexed for cases of advanced…”
    Get more information
    Journal Article
    Save to List
    Saved in:
  5. 5
    Study on prediction of early adverse events by CapeOX therapy in patients with colorectal cancer

    Study on prediction of early adverse events by CapeOX therapy in patients with colorectal cancer by Kumihashi, Yuki, Kasai, Yohei, Akagawa, Takuya, Yuasa, Yasuhiro, Ishikura, Hisashi, Sato, Youichi

    Published in The journal of medical investigation : JMI (01-02-2024)
    “…CapeOX is a regimen used as postoperative adjuvant chemotherapy for the treatment of advanced recurrent colorectal cancer. If early adverse events occur,…”
    Get more information
    Journal Article
    Save to List
    Saved in:

Search Tools: